19/06/2003
DISCLOSURE OF NOTIFIABLE INTEREST – DISPOSAL OF SHARES
ReGen Therapeutics Plc (the ‘Company’) announces that it today received notification from New Opportunities Investment Trust Plc that, following a disposal by it of 500,000 ordinary shares of the Company on 17 June 2003, it now retains a holding of 20,712,121 ordinary shares representing 12.87% of the issued share capital of the Company.
For further information, please contact:
Andrew Marshall
Marshall Robinson Roe
Tel. 020 7489 2033